Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2010
11/16/2010US7834239 Using expression vector comprising constitutive and/or tissue specific promoters and nucleotide sequences coding green/blue fluorescent protein to generate genetically engineered fish which fluoresce when exposed to sun, blue and ultraviolet light
11/16/2010US7834237 Membrane-localisable fusion protein of an aggregating portion induced through conformational polymerisation
11/16/2010US7834169 P300 histone acetylase inhibitor
11/16/2010US7834168 Detecting an elite event EE-GH1 specific region with a primer or probe; amplifying DNA; kits; optimal agronomic performance
11/16/2010US7834166 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
11/16/2010US7834165 Nucleic acid sequence and vectors encoding chimeric human T1R3 taste receptor
11/16/2010US7834159 Pharmacokinetics; glycosyltransferases; vaccines
11/16/2010US7834158 Mutated immunoglobulin-binding protein
11/16/2010US7834156 Monoclonal antibody comprising cytotoxic fusion for use in treatment of cell proliferative disorers
11/16/2010US7834152 Antagonists of interleukin-15
11/16/2010US7834151 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides; wound healing agents
11/16/2010US7834150 Isolated cold-and-menthol-sensitive receptor (CMR1)
11/16/2010US7834149 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis nervous system disorders and infections
11/16/2010US7834147 Saposin C-DOPS: a novel anti-tumor agent
11/16/2010US7834146 Recombinant polypeptides associated with plants
11/16/2010US7834143 Cell surface receptor for use as tool in identifying modulators of vascular pressure
11/16/2010US7834142 has stronger simulation to islet cell captors and stronger insulin secretion stimulation action; the reconstructed simulation sequence can resist dipeptidyl peptidase decomposition by change of the second aminoacid sequence from Ala to Gly or Ser to prolong its half time and enhance drug action
11/16/2010US7834141 Antiproliferative agents; gonadotropin releasing factor; binding to tumor and cancer cells; Chicken II GnRH analog; resistant to degradation by post-proline peptidases
11/16/2010US7834088 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
11/16/2010US7833988 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents
11/16/2010US7833983 polypeptide comprising a symmetrical dimethylated arginine, is used for diagnosing systemic lupus erythematosus
11/16/2010US7833981 glycoprotein having the removal of sialic acid from the end of the glycoside chain; for treatment of infectious and inflammatory diseases, female fertility disorders, autoimmune disorders, tumors, fungal infections
11/16/2010US7833979 conjugated polymer drug contains toxin protein and polyethylene glycol; treating autoimmune diseases, such as multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, dermatitis, rheumatoid arthritis, psoriasis; asthma, allergy, restinosis, fibrosis, scleroderma, glomerulonephritis
11/16/2010US7833977 Use of L-carnitine for the treatment of cataract of non diabetic origin due to altered chaperone proteins by stabilizing the protein activity
11/16/2010US7833975 biodrug protein having binding activity to an abnormal polyglutamine protein produced in a neurodegenerative disease; drug screening
11/16/2010US7833974 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders
11/16/2010US7833973 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions
11/16/2010US7833972 Proteins and use thereof
11/16/2010US7833971 Uses of cerberus, coco and derivatives thereof
11/16/2010US7833968 administering the NELL peptide encoded by a nucleotide sequence; inducing osteoblast or bone formation
11/16/2010US7833967 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
11/16/2010US7833963 For use as an anticancer agent and an immunosuppressive agent
11/16/2010US7833791 Lactobacilli expressing biologically active polypeptides and uses thereof
11/16/2010US7833783 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
11/16/2010US7833769 McrA variants and uses thereof
11/16/2010US7833768 Polypeptides having phytase activity
11/16/2010US7833753 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally
11/16/2010US7833750 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
11/16/2010US7833749 used as a reporter gene for cellular systems in combination with bioluminescent or chemoluminescent systems; for energy transfer systems
11/16/2010US7833722 Ligands for G protein-coupled receptor protein and use thereof
11/16/2010US7833718 CACNA1C nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death
11/16/2010US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development
11/16/2010US7833703 Method for the construction of randomized gene sequence libraries in cells
11/16/2010US7833702 Replication protein
11/16/2010US7833700 Kit for use in lysis and isolation of viral enzymatic polypeptides
11/16/2010US7833536 Combating the pathogenic effects of Mycoplasma infection in an animal by administering an effective amount of isolated and purified mycoplasmal L-alpha-glycerophosphate oxidase or an immunogenic fragment thereof, and a pharmaceutically acceptable carrier
11/16/2010US7833535 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction
11/16/2010US7833532 synthetic molecules comprising co-linear T-helper and CTL epitopes; enhanced ability to activate a T cell response to a CD8+ T cell epitope to induce cell mediated immunity against an invading pathogen or tumour cell
11/16/2010US7833529 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting transmembrane activator and CAML-interactor (TACI)//BCMA ; autoimmune disease; inflammation
11/16/2010US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon
11/16/2010US7833520 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
11/16/2010CA2523216C Recombinant alphavirus vectors
11/16/2010CA2455223C Crfr1 selective ligands
11/16/2010CA2439179C Methods and materials for making and using transgenic dicamba-degrading organisms
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2311648C Ifnar2/ifn complex
11/16/2010CA2278151C Heregulin variants
11/16/2010CA2237159C Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates
11/16/2010CA2197804C Method for the production of recombinant proteins, plasmids and modified cells
11/13/2010CA2666008A1 A method for water purification
11/11/2010WO2010129895A2 Cd133 epitopes
11/11/2010WO2010129805A1 Shoc2 mutations causing noonan-like syndrome with loose anagen hair
11/11/2010WO2010129789A2 Modified tumor necrosis factor-beta
11/11/2010WO2010129784A2 Isolated a-type fhf n-terminal domain peptides and methods of use
11/11/2010WO2010129655A2 Natriuretic polypeptides having mutations within their disulfide rings
11/11/2010WO2010129503A1 Fgf21 mutants and uses thereof
11/11/2010WO2010129501A1 Yield enhancement in plants by modulation of ap2 transcription factor
11/11/2010WO2010129418A1 Lat adapter molecule for enhanced t-cell signaling and method of use
11/11/2010WO2010129347A2 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
11/11/2010WO2010129294A2 Small molecules supporting pluripotent cell growth and methods thereof
11/11/2010WO2010129265A2 Compositions comprising monomeric streptavidin and methods for using same
11/11/2010WO2010129023A2 Supercharged proteins for cell penetration
11/11/2010WO2010128742A1 Cancer diagnosis method using the glycosylation of a glycoprotein
11/11/2010WO2010128521A2 Short-chain peptides as parathyroid hormone (pth) receptor agonist
11/11/2010WO2010128393A1 Method and composition for measuring the amount of vitamin d derivatives
11/11/2010WO2010128285A2 Method of modifying serine protease inhibitors
11/11/2010WO2010128159A1 Novel heamoglobin and uses thereof
11/11/2010WO2010128142A1 Method for purifying albumin
11/11/2010WO2010128141A1 Stable pharmaceutical compositions of peptide derivatized using an oxime linker
11/11/2010WO2010128098A1 Peptide ligands of somatostatin receptors
11/11/2010WO2010128033A2 Method for purification of target polypeptides
11/11/2010WO2010128032A1 Cho / cert cell lines
11/11/2010WO2010127969A1 Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same
11/11/2010WO2010127939A1 Recombinant human alpha1-antitrypsin
11/11/2010WO2010127712A1 Influenza a and b virus replication-inhibiting peptides
11/11/2010WO2010127640A1 High penetration prodrug compositions of peptides and peptide-related compounds
11/11/2010WO2010127398A1 Plasmodial polynucleotides, proteins and uses thereof
11/11/2010WO2010103515A3 Compositions and methods for prevention and treatment of neurodegenerative diseases
11/11/2010WO2010091651A3 Novel antimicrobial peptides
11/11/2010WO2010085100A3 Novel cellular transmembrane domain and intracellular transduction system containing the same
11/11/2010WO2010081492A8 Melanocortin analogs with antimicrobial activity
11/11/2010WO2010064258A3 Pharmaceutical formulations of pegylated interferon
11/11/2010WO2009142773A9 Multivalent fibronectin based scaffold domain proteins
11/11/2010WO2007133835A8 Ras mutation and compositions and methods related thereto
11/11/2010WO2004062646A9 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
11/11/2010WO2003040323A9 Bacterial ion channel and a method for screening ion channel modulators
11/11/2010US20100287672 Plant cell signaling genes
11/11/2010US20100287671 Stress-regulated genes of plants, transgenic plants containing same, and methods of use
11/11/2010US20100287664 Genes for enhancing resistance to magnaporthe oryzae and uses thereof
11/11/2010US20100287662 Maize Stress-Responsive NAC Transcription Factors and Promoter and Methods of Use
1 ... 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 ... 2916